Crossmark

Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours

Crossref DOI link: https://doi.org/10.1186/s12885-023-10533-x

Published Online: 2023-01-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Fujun

Yang, Yao

Du, Xiuzhen

Zhu, Xiaoying

Hu, Yanjiao

Lu, Changyu

Sui, Lei

Zhao, Han

Song, Kejuan

Yao, Qin
Funding

Funding for this research was provided by:

Qingdao Medical and health Scientific Research Plan Project (2021-WJZD201)

Science and Technology Bureau of Qingdao West Coast New Area (2020-53)
License Information

Text and Data Mining valid from 2023-01-13

Version of Record valid from 2023-01-13
More Information

Article History

Received: 12 October 2022

Accepted: 9 January 2023

First Online: 13 January 2023

Declarations

:

: All experiments were performed in accordance with the Declaration of Helsinki. All study subjects gave informed consent, and the study protocol was approved by the Medical Research Ethics Committee of Qingdao University Affiliated Hospital.

: All authors reviewed and approved the final manuscript.

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below